SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks 2 Minute Medicine , 20 Sep 2019 1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA…